103 related articles for article (PubMed ID: 12214252)
1. Roles of BRCA1 in centrosome duplication.
Deng CX
Oncogene; 2002 Sep; 21(40):6222-7. PubMed ID: 12214252
[TBL] [Abstract][Full Text] [Related]
2. Centrosome amplification, chromosome instability and cancer development.
Fukasawa K
Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
Shinmura K; Bennett RA; Tarapore P; Fukasawa K
Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
[TBL] [Abstract][Full Text] [Related]
4. GFP-centrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7.
D'Assoro AB; Stivala F; Barrett S; Ferrigno G; Salisbury JL
Ital J Anat Embryol; 2001; 106(2 Suppl 1):103-10. PubMed ID: 11729945
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle.
Ko MJ; Murata K; Hwang DS; Parvin JD
Oncogene; 2006 Jan; 25(2):298-303. PubMed ID: 16170356
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E-dependent localization of MCM5 regulates centrosome duplication.
Ferguson RL; Maller JL
J Cell Sci; 2008 Oct; 121(Pt 19):3224-32. PubMed ID: 18799789
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
D'Assoro AB; Busby R; Suino K; Delva E; Almodovar-Mercado GJ; Johnson H; Folk C; Farrugia DJ; Vasile V; Stivala F; Salisbury JL
Oncogene; 2004 May; 23(23):4068-75. PubMed ID: 15064746
[TBL] [Abstract][Full Text] [Related]
8. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the Nijmegen breakage syndrome gene leads to excess centrosome duplication via the ATR/BRCA1 pathway.
Shimada M; Sagae R; Kobayashi J; Habu T; Komatsu K
Cancer Res; 2009 Mar; 69(5):1768-75. PubMed ID: 19244116
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription.
Somasundaram K
J Cell Biochem; 2003 Apr; 88(6):1084-91. PubMed ID: 12647291
[TBL] [Abstract][Full Text] [Related]
11. [Centrosome isolation from cultured bladder cancer cells--p53 mutation and centrosome hyperamplification].
Kawamura K; Moriyama M; Suga K; Shiba N; Tanaka T; Ikeda R; Suzuki K
Hinyokika Kiyo; 2003 Feb; 49(2):69-74. PubMed ID: 12696185
[TBL] [Abstract][Full Text] [Related]
12. Loss of p53 and centrosome hyperamplification.
Tarapore P; Fukasawa K
Oncogene; 2002 Sep; 21(40):6234-40. PubMed ID: 12214254
[TBL] [Abstract][Full Text] [Related]
13. Centrosome function in normal and tumor cells.
Sankaran S; Parvin JD
J Cell Biochem; 2006 Dec; 99(5):1240-50. PubMed ID: 16817224
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Dopazo J; Rivas C; Benítez J
Breast Cancer Res Treat; 2005 Mar; 90(1):5-14. PubMed ID: 15770521
[TBL] [Abstract][Full Text] [Related]
15. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
[TBL] [Abstract][Full Text] [Related]
16. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.
Xu X; Weaver Z; Linke SP; Li C; Gotay J; Wang XW; Harris CC; Ried T; Deng CX
Mol Cell; 1999 Mar; 3(3):389-95. PubMed ID: 10198641
[TBL] [Abstract][Full Text] [Related]
17. Mechanism limiting centrosome duplication to once per cell cycle.
Tsou MF; Stearns T
Nature; 2006 Aug; 442(7105):947-51. PubMed ID: 16862117
[TBL] [Abstract][Full Text] [Related]
18. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.
Winter SL; Bosnoyan-Collins L; Pinnaduwage D; Andrulis IL
BMC Cancer; 2007 May; 7():85. PubMed ID: 17511879
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies.
Duensing S; Duensing A; Lee DC; Edwards KM; Piboonniyom SO; Manuel E; Skaltsounis L; Meijer L; Münger K
Oncogene; 2004 Oct; 23(50):8206-15. PubMed ID: 15378001
[TBL] [Abstract][Full Text] [Related]
20. Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells.
You F; Chiba N; Ishioka C; Parvin JD
Oncogene; 2004 Jul; 23(34):5792-8. PubMed ID: 15122325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
